D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ATNM holding history
Actinium Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −29,337−100.0% | Sold out | Holders |
| Q2 2024 | 29,337 | $217.1K | <0.1% | +29,337 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −18,002−100.0% | Sold out | Holders |
| Q3 2023 | 18,002 | $106.6K | <0.1% | −10,752−37.4% | Reduced | Holders |
| Q2 2023 | 28,754 | $213.4K | <0.1% | −12,144−29.7% | Reduced | Holders |
| Q1 2023 | 40,898 | $386.5K | <0.1% | −236,222−85.2% | Reduced | Holders |
| Q4 2022 | 277,120 | $2.95M | <0.1% | +239,196+630.7% | Added | Holders |
| Q3 2022 | 37,924 | $280.0K | <0.1% | +20,600+118.9% | Added | Holders |
| Q2 2022 | 17,324 | $83.0K | <0.1% | −5,711−24.8% | Reduced | Holders |
| Q1 2022 | 23,035 | $118.0K | <0.1% | −2,438−9.6% | Reduced | Holders |
| Q4 2021 | 25,473 | $153.0K | <0.1% | −2,646−9.4% | Reduced | Holders |
| Q3 2021 | 28,119 | $249.0K | <0.1% | +28,119 | New | Holders |